Persistent Cervical Carcinoma
1 clinical trials · Condition
◉ Watch Persistent Cervical Carcinoma
| Record | Firm | Date |
|---|---|---|
| Tislelizumab and Radiotherapy for Recurrent Cervical Cancer (NCT05310383) | Lei Li | 2022-03-27 |
Track Persistent Cervical Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.